Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 253-260

  Ma, Jing Xin ^a   Zhang, Kai Li ^a   Liu, Xu ^a   Ma, Yan Lu ^a   Pei, Li Na ^a   Zhu, Yi Fang ^a   Zhou, Lei ^a   Chen, Xiao Yan ^a   Kong, Qing You ^a   Li, Hong ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

AhR; CYP1A1 MspI polymorphism; Gastric cancer; Gene expression; Susceptibility

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; PROTEIN; PROTEIN MSPI; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER TISSUE; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR TRANSPORT; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; WESTERN BLOTTING;

CASE-CONTROL STUDIES; CELL NUCLEUS; CHINA; CYTOCHROME P-450 CYP1A1; DEOXYRIBONUCLEASE HPAII; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; PROTEIN TRANSPORT; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 33746341160     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.020     Document Type: Article

References (36)

1. Jeffrey M. China's unique environment favors large intervention trials. Science 270 (1995) 1149-1151
2. Sinha R., and Rothman N. Role of well-done, grilled red meat, heterocyclic amines (HCAs) in the etiology of human cancer. Cancer Lett. 143 (1999) 189-194
3. Athar M., Khan W.A., and Mukhtar H. Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res. 49 (1989) 5784-5788
4. Tatemichi M., Nomura S., Ogura T., Sone H., Nagata H., and Esumi H. Mutagenic activation of environmental carcinogens by microsomes of gastric mucosa with intestinal metaplasia. Cancer Res. 59 (1999) 3893-3898
5. Shimada T., and Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 95 (2004) 1-6
6. Anttila S., Tuominen P., Hirvonen A., Nurminen M., Karjalainen A., Hankinson O., and Elovaara E. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11 (2001) 501-509
7. Brockdorff B.L., Skouv J., Reiter B.E., and Lykkesfeldt A.E. Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines. Int. J. Cancer 88 (2000) 902-906
8. Nakachi K., Imai K., Hayashi S., Watanabe J., and Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 51 (1991) 5177-5180
9. Sivaraman L., Leatham M.P., Yee J., Wilkens L.R., Lau A.F., and Le Marchand L. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res. 54 (1994) 3692-3695
10. Yengi L., Inskip A., Gilford J., Alldersea J., Bailey L., Smith A., et al. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res. 56 (1996) 1974-1977
11. Suzuki S., Muroishi Y., Nakanishi I., and Oda Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J. Gastroenterol. 39 (2004) 220-230
12. Lei X.D., Chapman B., and Hankinson O. Loss of cyp1a1 messenger rna expression due to nonsense-mediated decay. Mol. Pharmacol. 60 (2001) 388-393
13. Angus W.G., Larsen M.C., and Jefcoate C.R. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis 20 (1999) 947-955
14. Murray G.L., Taylor M.C., Burke M.D., and Melvin W.T. Enhanced expression of cytochrome P450 in stomach cancer. Br. J. Cancer 77 (1998) 1040-1044
15. Zhang K.L., Ma J.X., Chen X.Y., Sun Y., Kong Q.Y., Liu J., and Li H. Frequent CYP1A1 expression in gastric cancers and their related lesions. Oncol. Rep. 12 (2004) 1335-1340
16. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response. Cell cycle control, and apoptosis. Biochem. Pharmacol. 59 (2000) 65-85
17. Li H., Lee G.H., Liu J., Nomura K., Ohtake K., and Kitagawa T. Low frequency of ras activation in 2-acetylaminofluorene- and 3'-methyl-4-(dimethylamino)azobenzene-induced rat hepatocellular carcinomas. Cancer Lett. 56 (1991) 17-24
18. Wu M.T., Huang S.L., Ho C.K., Yeh Y.F., and Christiani D.C. Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 823-829
19. Li H., Sun Y., Kong Q.Y., Zhang K.L., Wang X.W., Chen X.Y., et al. Combination of nucleic acid and protein isolation with tissue array construction: using defined histologic regions in single frozen tissue blocks for multiple research purposes. Int. J. Mol. Med. 12 (2003) 299-304
20. Yang J.H., Christophl V., and Josef A. A malignant transformation of human cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits altered expression of growth regulatory factors. Carcinogenesis 20 (1999) 13-18
21. Erichsen H.C., and Chanock S.J. SNPs in cancer research and treatment. Br. J. Cancer 90 (2004) 747-751
22. Quiñones L., Berthou F., Varela N., Simon B., Gil L., and Lucas D. Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French caucasian and chilean populations. Cancer Lett. 141 (1999) 167-171
23. Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis 19 (1998) 1329-1332
24. Crofts F., Cosma G.N., Taioli E., Currie D., Toniolo P.T., and Garte S.J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 14 (1993) 1729-1731
25. Kiyohara C., Hirohata T., and Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn. J. Cancer Res. 87 (1996) 18-24
26. Wu M.T., Lee J.M., Wu D.C., Ho C.K., Wang Y.T., Lee Y.C., et al. Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan. Br. J. Cancer 87 (2002) 529-532
27. Whitlock J. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 103-125
28. Spink S.C., Hussain M.M., Katz B.H., Eisele L., and Spink D.C. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem. Pharmacol. 66 (2003) 2313-2321
29. Lin P., Chang H., Tsai W.T., Wu M.H., Liao Y.S., Chen J.T., and Su J.M. Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxic. Pathol. 31 (2003) 22-30
30. Andersson P., McGuire J., Rubio C., Gradin K., Whitelaw M.L., Pettersson S., et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc. Natl Acad. Sci. USA 99 (2002) 9990-9995
31. Lin P., Hu S.W., and Chang T.H. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol. Sci. 71 (2003) 20-26
32. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA 97 (2000) 779-782
33. Baccarelli A., Pesatori A.C., Masten S.A., Patterson D.G., Needham L.L., Mocarelli P., et al. Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in seveso, Italy. Toxicol. Lett. 149 (2004) 287-293
34. Murayama T., Inoue M., Nomura T., Mori S., and Eizuru Y. 2,3,7,8-Tetrachlorodibenzo-p-dioxin is a possible activator of human cytomegalovirus replication in a human fibroblast cell line. Biochem. Biophys. Res. Commun. 296 (2002) 651-656
35. Vaziri C., Schneider A., Sherr D.H., and Faller D.V. Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts. J. Biol. Chem. 271 (1996) 25921-25927
36. Wu M.L., Li H., Wu D.C., Wang X.W., Kong Q.Y., Ma J.X., et al. CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis. Neurosci. Lett. 384 (2005) 33-37